Grifols GIKLY
ADR · ADR · CUSIP 398438200
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNew York, NY
- FilingsSEC EDGAR
1
institutional holders
+0 vs Q1 2021
2.0k
shares reported held*
$27.0kreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $13.68.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2021 | 1 | 0 |
| Q2 2021 | 0 | 0 |
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2021.
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| DSM CAPITAL PARTNERS LLC 0.00% of their portfolio | 2.0k $27.0k | Unchanged |